112 related articles for article (PubMed ID: 25829429)
1. Biomarkers in COPD: the search continues!
Mannino DM
Eur Respir J; 2015 Apr; 45(4):872-4. PubMed ID: 25829429
[No Abstract] [Full Text] [Related]
2. Plasma pro-surfactant protein B and lung function decline in smokers.
Leung JM; Mayo J; Tan W; Tammemagi CM; Liu G; Peacock S; Shepherd FA; Goffin J; Goss G; Nicholas G; Tremblay A; Johnston M; Martel S; Laberge F; Bhatia R; Roberts H; Burrowes P; Manos D; Stewart L; Seely JM; Gingras M; Pasian S; Tsao MS; Lam S; Sin DD;
Eur Respir J; 2015 Apr; 45(4):1037-45. PubMed ID: 25614175
[TBL] [Abstract][Full Text] [Related]
3. [Echoes of the ECLIPSE study].
Mihălţan Florin
Pneumologia; 2014; 63(3):142-3. PubMed ID: 25420288
[No Abstract] [Full Text] [Related]
4. Screening for Lung Cancer: What Comes Next?
Peled N; Ilouze M
J Clin Oncol; 2015 Nov; 33(33):3847-8. PubMed ID: 26304887
[No Abstract] [Full Text] [Related]
5. Serum Cystatin C as an Inflammatory Marker in Exacerbated and Convalescent COPD Patients.
Zhang M; Li Y; Yang X; Shan H; Zhang Q; Ming Z; Xie Y; Chen H; Liu Y; Zhang J
Inflammation; 2016 Apr; 39(2):625-31. PubMed ID: 26613760
[TBL] [Abstract][Full Text] [Related]
6. Differences in systemic inflammation between cigarette and biomass smoke-induced COPD.
Golpe R; Martín-Robles I; Sanjuán-López P; Pérez-de-Llano L; González-Juanatey C; López-Campos JL; Arellano-Orden E
Int J Chron Obstruct Pulmon Dis; 2017; 12():2639-2646. PubMed ID: 28979110
[TBL] [Abstract][Full Text] [Related]
7. [Pulmonary surfactant proteins SP-A and SP-D].
Kuroki Y; Takahashi H
Nihon Rinsho; 1999 Aug; 57 Suppl():309-12. PubMed ID: 10503429
[No Abstract] [Full Text] [Related]
8. Procalcitonin-guided antibiotic therapy in COPD exacerbations: closer but not quite there.
Martinez FJ; Curtis JL
Chest; 2007 Jan; 131(1):1-2. PubMed ID: 17218546
[No Abstract] [Full Text] [Related]
9. Pulmonary surfactant protein A: a serum marker of pulmonary fibrosis in patients with collagen vascular diseases.
Takahashi H; Honda Y; Kuroki Y; Imai K; Abe S
Clin Chim Acta; 1995 Aug; 239(2):213-5. PubMed ID: 8542661
[No Abstract] [Full Text] [Related]
10. Proteomic biomarkers in plasma that differentiate rapid and slow decline in lung function in adult cigarette smokers with chronic obstructive pulmonary disease (COPD).
Rana GS; York TP; Edmiston JS; Zedler BK; Pounds JG; Adkins JN; Varnum SM; Smith RD; Liu Z; Li G; Webb BT; Murrelle EL; Flora JW
Anal Bioanal Chem; 2010 Jul; 397(5):1809-19. PubMed ID: 20442989
[TBL] [Abstract][Full Text] [Related]
11. Biomarkers in COPD.
Agusti A; Sin DD
Clin Chest Med; 2014 Mar; 35(1):131-41. PubMed ID: 24507841
[TBL] [Abstract][Full Text] [Related]
12. Unifying thoracic biomarkers: surfactant protein-D and beyond.
Jaw JE; Sin DD
Expert Rev Respir Med; 2012 Apr; 6(2):147-54. PubMed ID: 22455487
[TBL] [Abstract][Full Text] [Related]
13. Surfactant protein-B 121ins2 heterozygosity, reduced pulmonary function, and chronic obstructive pulmonary disease in smokers.
Baekvad-Hansen M; Dahl M; Tybjaerg-Hansen A; Nordestgaard BG
Am J Respir Crit Care Med; 2010 Jan; 181(1):17-20. PubMed ID: 19833825
[TBL] [Abstract][Full Text] [Related]
14. Exertional hypoxemia in stable COPD is common and predicted by circulating proadrenomedullin.
Stolz D; Boersma W; Blasi F; Louis R; Milenkovic B; Kostikas K; Aerts JG; Rohde G; Lacoma A; Rakic J; Boeck L; Castellotti P; Scherr A; Marin A; Hertel S; Giersdorf S; Torres A; Welte T; Tamm M
Chest; 2014 Aug; 146(2):328-338. PubMed ID: 24722847
[TBL] [Abstract][Full Text] [Related]
15. Serum Amyloid-Beta Levels are Increased in Patients with Chronic Obstructive Pulmonary Disease.
Bu XL; Cao GQ; Shen LL; Xiang Y; Jiao SS; Liu YH; Zhu C; Zeng F; Wang QH; Wang YR; He Y; Zhou HD; Wang YJ
Neurotox Res; 2015 Nov; 28(4):346-51. PubMed ID: 26243505
[TBL] [Abstract][Full Text] [Related]
16. Plasma cytokine profiles related to smoking-sensitivity and phenotypes of chronic obstructive pulmonary disease.
Nakamura M; Nakamura H; Minematsu N; Chubachi S; Miyazaki M; Yoshida S; Tsuduki K; Shirahata T; Mashimo S; Takahashi S; Nakajima T; Tateno H; Fujishima S; Betsuyaku T
Biomarkers; 2014 Aug; 19(5):368-77. PubMed ID: 24842387
[TBL] [Abstract][Full Text] [Related]
17. Roflumilast for chronic obstructive pulmonary disease.
Morice AH
Lancet; 2005 Nov; 366(9500):1845; author reply 1846-7. PubMed ID: 16310544
[No Abstract] [Full Text] [Related]
18. The value of assessment tests in patients with acute exacerbation of chronic obstructive pulmonary disease.
Zhao YF; Jiang YP; Zhou LF; Wu XL
Am J Med Sci; 2014 May; 347(5):393-9. PubMed ID: 24270077
[TBL] [Abstract][Full Text] [Related]
19. Inflammatory biomarkers and exacerbations in chronic obstructive pulmonary disease.
Thomsen M; Ingebrigtsen TS; Marott JL; Dahl M; Lange P; Vestbo J; Nordestgaard BG
JAMA; 2013 Jun; 309(22):2353-61. PubMed ID: 23757083
[TBL] [Abstract][Full Text] [Related]
20. [Systemic markers of exacerbated chronic obstructive pulmonary disease: how they can help with the decision of whether or not to prescribe antibiotics].
Soler N
Arch Bronconeumol; 2008 Nov; 44(11):581-3. PubMed ID: 19007562
[No Abstract] [Full Text] [Related]
[Next] [New Search]
